MEI Pharma (MEIP) Stock: Here’s What You Need To Know

MEI Pharma Inc. (NASDAQ:MEIP) On Monday, MEI pharma released results of its phase 2 clinical trial in elderly patients with Acute Myeloid Leukemia – AML. These results were presented at a prestigious medical conference known as the American Society of Hematology or ASH. The results themselves were outstanding, but the stock didn’t budge at all. … Read more

MEI Pharma Stocks Plummet | Poor Trial Results To Blame

MEI Pharma Inc – (NASDAQ: MEIP) MEI Pharma stocks have been plummeting today; falling by nearly 70% so far (12:44). The drop is due to the latest release of clinical testing data of their investigatory cancer drug, Pracinostat. So, today we’ll talk about the trial results and why investors are dumping the stock left and … Read more